Novo Nordisk A/S
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment pro…
Biotechnology
DK, Bagsvaerd [HQ]
Ratios
15 Sheets · Starting from 2023Margins, Growth Rates In %
| Ratio | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||||||||
| Gross Margin | 79.56 | 80.78 | 81.03 | 82.74 | 83.08 | 83.60 | 85.00 | 84.63 | 84.21 | 84.25 | 83.54 | 83.51 | 83.20 | 83.92 | 84.60 | |
| Profit Margin | 21.08 | 23.70 | 25.77 | 27.47 | 30.13 | 29.82 | 32.30 | 33.93 | 34.14 | 34.54 | 31.92 | 33.19 | 33.92 | 31.38 | 36.03 | |
| Operating Margin | 29.24 | 31.08 | 33.72 | 37.77 | 37.68 | 38.84 | 45.81 | 43.33 | 43.84 | 42.25 | 43.01 | 42.64 | 41.65 | 42.28 | 44.16 | |
|
EPS Growth
|
14.70 | 38.16 | 21.98 | 29.26 | 20.21 | 7.45 | 34.26 | -44.69 | 2.80 | 3.50 | 2.76 | 10.12 | 15.17 | 17.89 | 52.28 | |
| EPS DKK | 359.00 | 496.00 | 605.00 | 782.00 | 940.00 | 1,010.00 | 1,356.00 | 750.00 | 771.00 | 798.00 | 820.00 | 903.00 | 1,040.00 | 1,226.00 | 1,867.00 | |
| Return on Assets (ROA) | 19.67 | 23.46 | 26.43 | 32.64 | 35.80 | 34.36 | 37.97 | 38.88 | 37.25 | 34.87 | 31.01 | 29.08 | 24.55 | 23.01 | 26.61 | |
| Return on Equity (ROE) | 30.13 | 38.96 | 45.66 | 52.75 | 59.16 | 65.72 | 74.22 | 83.78 | 76.54 | 74.52 | 67.63 | 66.54 | 67.50 | 66.51 | 78.53 | |
| Return on Invested Capital (ROIC) | 30.97 | 37.97 | 45.55 | 55.22 | 56.97 | 65.32 | 82.51 | 84.46 | 74.46 | 73.21 | 67.83 | 58.26 | 48.67 | 55.04 | 61.40 | |
| Solvency | ||||||||||||||||
| Equity Ratio | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | - - | |
| Debt/Assets | 2.54 | 3.62 | 1.32 | 0.76 | 0.31 | 0.93 | 1.17 | 0.24 | 1.66 | 0.47 | 3.57 | 7.15 | 13.70 | 10.69 | 8.59 | |
| Debt/Equity | 3.88 | 6.02 | 2.28 | 1.23 | 0.51 | 1.79 | 2.28 | 0.51 | 3.40 | 0.99 | 7.78 | 16.35 | 37.66 | 30.88 | 25.34 | |
| Debt/EBITDA | -54.44 | -45.05 | -56.06 | -34.32 | -29.99 | -35.90 | -30.20 | -35.77 | -32.89 | -29.56 | -19.02 | -3.99 | 23.57 | 16.01 | 11.17 | |
|
Debt/Capitalization
|
3.74 | 5.68 | 2.23 | 1.22 | 0.50 | 1.76 | 2.23 | 0.50 | 3.29 | 0.98 | 7.22 | 14.06 | 27.36 | 23.60 | 20.22 | |
| Long-Term Debt/Capitalization | 2.64 | 1.35 | 1.32 | - - | - - | - - | - - | - - | - - | - - | 4.97 | 4.37 | 15.48 | 22.56 | 16.15 | |
| Interest Debt per Share DKK | 0.89 | 1.47 | 0.64 | 0.20 | 0.10 | 0.49 | 2.77 | 0.06 | 0.36 | 0.12 | 0.99 | 2.30 | 6.33 | 5.77 | 6.15 | |
| Debt Growth | -40.21 | 60.23 | -61.65 | -41.38 | -57.00 | 234.88 | 49.03 | -78.66 | 639.74 | -69.60 | 770.49 | 131.01 | 157.29 | -3.23 | 4.74 | |
| Liquidity | ||||||||||||||||
| Current Ratio | 243.50 | 201.85 | 190.53 | 185.61 | 173.61 | 137.41 | 134.91 | 125.99 | 127.68 | 109.05 | 105.89 | 93.65 | 86.01 | 89.46 | 82.31 | |
| Quick Ratio | 154.22 | 136.40 | 144.91 | 137.21 | 122.37 | 103.61 | 102.95 | 94.65 | 95.01 | 78.52 | 75.66 | 63.95 | 64.60 | 67.04 | 62.18 | |
| Cash Ratio | 84.20 | 65.04 | 64.53 | 53.39 | 44.28 | 42.73 | 41.40 | 39.40 | 40.06 | 28.87 | 26.24 | 18.15 | 10.77 | 10.46 | 8.48 | |
| Operating Cash Flow Ratio | 100 | 100 | 100 | 100 | 100 | - - | - - | 100 | - - | - - | - - | - - | - - | - - | - - | |
| Turnover | ||||||||||||||||
| Inventory Turnover | 104.21 | 120.55 | 133.46 | 141.10 | 148.03 | 128.22 | 126.89 | 119.82 | 114.70 | 107.84 | 113.87 | 112.93 | 120.58 | 116.65 | 112.43 | |
| Receivables Turnover | 649.68 | 664.22 | 526.22 | 574.40 | 550.76 | 467.38 | 499.36 | 461.96 | 474.27 | 415.90 | 418.57 | 394.44 | 300.86 | 307.72 | 308.61 | |
| Payables Turnover | 465.57 | 401.93 | 382.53 | 348.93 | 345.55 | 294.18 | 328.56 | 285.86 | 314.30 | 260.76 | 315.95 | 366.14 | 266.72 | 182.51 | 139.67 | |
|
Asset Turnover
|
93.31 | 98.98 | 102.55 | 118.82 | 118.82 | 115.24 | 117.57 | 114.60 | 109.13 | 100.96 | 97.14 | 87.60 | 72.39 | 73.35 | 73.85 | |
| Fixed Turnover | 265.67 | 296.37 | 316.97 | 362.25 | 381.92 | 383.84 | 422.50 | 370.39 | 316.90 | 266.96 | 241.38 | 252.53 | 254.33 | 265.41 | 255.34 | |
| Coverage | ||||||||||||||||
| Interest Coverage | 1,180.47 | 918.38 | 2,333.06 | 50,817.24 | 57,260.00 | 6,126.47 | 817.80 | 74,510.77 | 54,407.78 | 55,585.88 | 23,855.91 | 13,878.46 | 2,392.66 | 19,790.74 | 18,925.09 | |
| Asset Coverage | 2,900 | 1,900 | 5,000 | 8,600 | 20,700 | 5,900 | 4,600 | 20,700 | 3,100 | 10,000 | 1,300 | 500 | 200 | 200 | 300 | |
| Cash Flow Coverage (CFGR) | 1,107.93 | 884.85 | 2,505.74 | 4,442.80 | 12,066.05 | 4,401.67 | 3,568.22 | 21,097.82 | 2,430.22 | 8,663.30 | 1,043.54 | 501.65 | 206.42 | 305.95 | 403.27 | |
| EBITDA Coverage | 1,400 | 1,000 | 2,300 | 55,500 | 63,700 | 6,700 | 800 | 79,400 | 57,900 | 60,100 | 26,200 | 15,400 | 2,700 | 21,700 | 20,800 | |
| Dividend Coverage | - - | -300 | -200 | -200 | -200 | -200 | -200 | -100 | -200 | -200 | -200 | -200 | -200 | -200 | -200 | |
| Time Interest Earned (TIE) | 100 | 100 | 100 | 100 | 100 | 100 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | 200 | |
| Market Prospects | ||||||||||||||||
| Dividend Yield | - - | 2.42 | 3.05 | 3.06 | 3.63 | 3.48 | 2.52 | 3.72 | 2.29 | 2.62 | 2.12 | 2.03 | 1.28 | 1.19 | 1.01 | |
| Earnings Yield | 10.83 | 7.91 | 9.15 | 8.47 | 9.40 | 7.76 | 6.80 | 5.92 | 4.63 | 5.32 | 4.25 | 4.24 | 2.84 | 2.61 | 2.67 | |
|
Price/Earnings (P/E)
|
923.65 | 1,263.73 | 1,093.35 | 1,180.25 | 1,063.75 | 1,289.19 | 1,470.38 | 1,690.61 | 2,159.78 | 1,879.59 | 2,351.18 | 2,356.07 | 3,520.97 | 3,834.83 | 3,741.80 | |
| Price/Earnings Growth (PEG) | 62.85 | 33.12 | 49.75 | 40.34 | 52.65 | 173.12 | 42.92 | -37.83 | 771.35 | 536.73 | 852.84 | 232.77 | 232.08 | 214.42 | 71.57 | |
|
Price/Book (P/B)
|
278.33 | 492.40 | 499.17 | 622.54 | 629.32 | 847.25 | 1,091.31 | 1,416.35 | 1,653.17 | 1,400.58 | 1,590.14 | 1,567.79 | 2,376.83 | 2,550.47 | 2,938.46 | |
| Price/Tangible Book (P/TB) | 278.33 | 492.40 | 499.17 | 622.54 | 629.32 | 847.25 | 1,091.31 | 1,416.35 | 1,653.17 | 1,400.58 | 1,590.14 | 1,567.79 | 2,376.83 | 2,550.47 | 2,938.46 | |
| Price/Sales (P/S) | 194.72 | 299.48 | 281.75 | 324.19 | 320.56 | 384.42 | 474.93 | 573.60 | 737.29 | 649.24 | 750.53 | 782.07 | 1,194.25 | 1,203.30 | 1,348.16 | |
|
Price/Cash Flow (P/CF)
|
646.76 | 924.92 | 874.57 | 1,138.70 | 1,032.67 | 1,077.21 | 1,338.77 | 1,327.08 | 2,000.40 | 1,627.32 | 1,957.61 | 1,911.03 | 3,057.29 | 2,699.16 | 2,875.13 | |
| Price/Free CF (P/FCF) | 807.75 | 1,153.31 | 1,036.08 | 1,360.54 | 1,201.43 | 1,247.91 | 1,607.78 | 1,601.03 | 2,532.36 | 2,254.38 | 2,576.04 | 3,323.74 | 3,531.47 | 3,320.06 | 4,472.44 | |
| Price/Operating CF (P/OCF) | 646.76 | 924.92 | 874.57 | 1,138.70 | 1,032.67 | 1,077.21 | 1,338.77 | 1,327.08 | 2,000.40 | 1,627.32 | 1,957.61 | 1,911.03 | 3,057.29 | 2,699.16 | 2,875.13 |